Viewing Study NCT00101712


Ignite Creation Date: 2025-12-26 @ 11:10 AM
Ignite Modification Date: 2026-01-01 @ 1:19 AM
Study NCT ID: NCT00101712
Status: COMPLETED
Last Update Posted: 2012-05-07
First Post: 2005-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module